Hearing News Watch

Featured image for “Bill Austin Receives Prestigious Honorary Degree from Kenyatta University”
Dec. 16, 2024

Bill Austin Receives Prestigious Honorary Degree from Kenyatta University

HHTM
EDEN PRAIRIE, MINNESOTA – Starkey has announced that its Founder and Chairman, William F. Austin, has been awarded an honorary degree from Kenyatta University in recognition of his groundbreaking contributions to hearing healthcare and his unwavering commitment to serving disadvantaged communities in Africa and throughout the world. Bill Austin’s vision and generosity have touched millions of lives around the globe.
Featured image for “Demant Care Community Champions Respite Home for Women Battling Cancer”
Dec. 16, 2024

Demant Care Community Champions Respite Home for Women Battling Cancer

HHTM
SOMERSET, NEW JERSEY — On December 6th, Oticon President Gary Rosenblum and Mariann Cadieu, Executive Director of the Oticon Hearing Foundation, visited Mary’s Place by the Sea—a respite home dedicated to supporting women battling cancer. The facility received a generous donation raised through the dedicated efforts of Demant staff volunteers and sales promotions. During their visit, the team toured the
Featured image for “New Objective Diagnostic Tool Developed to Detect Hidden Hearing Loss and More”
Dec. 13, 2024

New Objective Diagnostic Tool Developed to Detect Hidden Hearing Loss and More

HHTM
Hearing loss, a condition affecting millions globally, often extends beyond the obvious symptoms captured by standard audiograms. Up to 10% of patients experiencing hearing difficulties have conditions that remain undiagnosed through conventional clinical tests. Addressing this unmet need, researchers at the University of Pittsburgh have developed a groundbreaking diagnostic tool for detecting hidden hearing pathologies, offering new hope for improved
Featured image for “Sound Pharmaceuticals Reports Positive Phase 3 Results for SPI-1005 in Meniere’s Disease”
Dec. 10, 2024

Sound Pharmaceuticals Reports Positive Phase 3 Results for SPI-1005 in Meniere’s Disease

HHTM
SEATTLE, WASHINGTON — Sound Pharmaceuticals announced today that its pivotal Phase 3 clinical trial evaluating SPI-1005, a novel anti-inflammatory compound (ebselen), for the treatment of Meniere’s Disease (STOPMD-3) successfully met its co-primary efficacy endpoints. These results demonstrate significant improvements in hearing loss and speech discrimination. Meniere’s disease (MD) is an inner ear disorder that causes fluctuating hearing loss, tinnitus, and
Featured image for “Call for Papers: Digital EUHA Spring Conference 2025”
Dec. 10, 2024

Call for Papers: Digital EUHA Spring Conference 2025

HHTM
The European Union of Hearing Aid Acousticians (EUHA) has announced the call for papers for its upcoming Digital EUHA Spring Conference, scheduled to begin on March 28, 2025. The conference, an established event in the hearing care community, attracts both members and non-members, including a significant number of international participants. The event will feature live presentations on the opening day,
Featured image for “USC Stem Cell Scientists Uncover Genetic Roadmap to Hearing Repair”
Dec. 09, 2024

USC Stem Cell Scientists Uncover Genetic Roadmap to Hearing Repair

HHTM
A new USC Stem Cell study published in the Proceedings of the National Academy of Sciences (PNAS), reveals the genetic mechanisms that enable fish and lizards to regenerate their hearing after injury. By identifying key gene regulators and DNA control elements, the research offers valuable insights into sensory cell regeneration, paving the way for potential therapeutic strategies to restore hearing
Featured image for “Cilcare Secures €40M Series A Funding to Advance Early Hearing Loss Treatments”
Dec. 06, 2024

Cilcare Secures €40M Series A Funding to Advance Early Hearing Loss Treatments

HHTM
MONTPELLIER, FRANCE – Cilcare, a biotechnology company specializing in auditory sciences, has announced the completion of its €40 million Series A funding round, with €21 million secured in the latest phase. This milestone was achieved with the participation of new investors, including SHIONOGI & CO., LTD., and Sprim Global Investments Pte. Ltd., as well as existing backers such as Sofilaro,
Featured image for “Neurotone AI Acquires Amptify to Advance the Future of Auditory Training”
Dec. 04, 2024

Neurotone AI Acquires Amptify to Advance the Future of Auditory Training

HHTM
GAINESVILLE, FLORIDA – Neurotone AI, a pioneer in aural rehabilitation and creator of Lace AI Pro, has announced a definitive agreement to acquire Amptify, a leading digital hearing healthcare platform developed at Washington University in St. Louis School of Medicine. The transaction, expected to close by the end of 2024, is subject to customary closing conditions. This acquisition aligns with
Featured image for “Dr. Douglas Beck Honored with 2024 “Golden Lobe” Award by AIHHP”
Dec. 04, 2024

Dr. Douglas Beck Honored with 2024 “Golden Lobe” Award by AIHHP

HHTM
CHARLESTON, SOUTH CAROLINA – Dr. Douglas L. Beck, co-host of the Hearing Matters Podcast, has been awarded the prestigious 2024 Golden Lobe Award by the Association of Independent Hearing Healthcare Professionals (AIHHP). This award is granted annually to a distinguished hearing healthcare professional who has made outstanding contributions to the field of audiology. Dr. Beck, renowned for being among the
Featured image for “New $3.2M NIDCD Grant Fuels Study on Protecting Inner-Ear Cells by Regulating Mitochondrial Calcium”
Dec. 03, 2024

New $3.2M NIDCD Grant Fuels Study on Protecting Inner-Ear Cells by Regulating Mitochondrial Calcium

HHTM
Case Western Reserve University and Mass Eye and Ear researchers have been awarded a five-year, $3.2 million grant from the National Institute on Deafness and Other Communication Disorders (NIDCD). The study aims to uncover the mechanisms behind acquired hearing loss (AHL) and explore strategies to prevent it. AHL is one of the most prevalent health issues among older adults, according